Multicyclic, Dose-Intensive Chemotherapy Supported by Hemopoietic Progenitors in Refractory Myeloma Patients

Bone Marrow Transplantation - United Kingdom
doi 10.1038/sj.bmt.1700599
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Low-Dose Lenalidomide and Dexamethasone Combination Treatment in Elderly Patients With Relapsed and Refractory Multiple Myeloma

Hematology
Hematology
2016English

Bendamustine in Patients With Relapsed or Refractory Multiple Myeloma

European Journal of Medical Research
Medicine
2010English

Single-Agent Thalidomide for Treatment of First Relapse Following High-Dose Chemotherapy in Patients With Multiple Myeloma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2004English

Posterior Reversible Encephalopathy Manifested by Refractory Status Epilepticus in Two Patients Under Chemotherapy

BMJ Case Reports
Medicine
2011English

Managing Neutropenia by Pegfilgrastim in Patients Affected by Relapsed/Refractory Multiple Myeloma Treated With Bendamustine-Bortezomib-Dexamethasone

Supportive Care in Cancer
Oncology
2016English

Leptotrichia Bacteremia in Patients Receiving High-Dose Chemotherapy

Journal of Clinical Microbiology
Microbiology
2011English

Autologous Stem Cell Transplantation Followed by Consolidation Chemotherapy for Patients With Multiple Myeloma

Bone Marrow Transplantation
TransplantationHematology
2005English

Infectious Complications in Patients With Multiple Myeloma on First Chemotherapy Cycle

Oncogematologiya
OncologyHematology
2018English

High Dose, Dose-Intensive Chemotherapy With Doxorubicin and Cyclophosphamide for the Treatment of Advanced Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
1993English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy